Predictors of in-hospital mortality in Fournier gangrene at four Korean tertiary hospitals: a multicenter retrospective cohort study
- Author:
In Sik SHIN
1
;
Sung Woo JANG
;
Chan Hee PARK
;
Jeong Woo LEE
;
Hui-Jae BANG
;
Kwangmin KIM
Author Information
- Publication Type:Original Article
- From: Journal of Acute Care Surgery 2025;15(3):99-107
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:Fournier gangrene (FG) is a life-threatening condition characterized by rapid tissue necrosis in the perineal and genital regions. Early identification of risk factors is essential for improving prognosis and reducing mortality rates. This study aimed to identify predictive factors associated with mortality in patients with FG.
Methods:A multi-institutional retrospective study was conducted across four tertiary care centers in Korea, including patients diagnosed with FG between January 2014 and December 2023. Data on demographic characteristics, laboratory findings, and clinical outcomes were collected. Independent risk factors for mortality were identified using multivariate logistic regression analysis, and optimal cutoff values for these predictors were determined.
Results:A total of 133 patients were included. The findings showed that age, initial lactate level, hemoglobin level, platelet count, and albumin level were significant predictors of mortality. Age was associated with an odds ratio of 1.105 (95% confidence interval [CI], 1.038–1.177; P=0.0018), while initial lactate level exhibited an odds ratio of 1.820 (95% CI, 1.335–2.480; P=0.0002). The optimal cutoff values identified were 64.5 years for age, 3.15 mmol/L for lactate, 8.65 g/dL for hemoglobin, 208×109/L for platelet count, and 3.05 g/dL for albumin, with varying sensitivity and specificity.
Conclusion:The study concluded that age, and initial levels of lactate, hemoglobin, albumin, and platelet count are independently predictive of mortality in patients with FG. These findings underscore the importance of aggressive management for patients presenting with abnormal serum values at admission to improve clinical outcomes. Further research is warranted to validate these results and to refine management strategies for FG.
